Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.

Pharmacoeconomics. 2003;21(7):497-9.

Tyagi V, Singh SK, Sawhney A, Taneja V, Puliyel JM.

Download 2.18MB